Deals in Depth: May 2008

01 Jul 2008

Executive Summary

May 2008 dealmaking highlights: BMS stood out, getting a Phase II cardiovascular agent from KAI, selling off its ConvaTec wound healing division to private equity, and acquiring Kosan BioSciences; total private placement dollars in biopharma companies ($496mm) was almost half what it was in the previous month, while private investments in device players were up 67% to $278mm.

Already Registered? Sign in to continue reading.

New to In Vivo? Start a free trial today!

Table
View full table

Topics

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Medical Device

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

IV003148

Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

IV003148

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Deals in Depth: May 2008

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Deals in Depth: May 2008

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert